Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma

por Miller, Catriona HT, Graham, Laura, Bear, Harry D
Publicado 2010

Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma

por Zoon, Christine Kathryn, Wan, Wen, Graham, Laura, Bear, Harry D.
Publicado 2015

Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary Carcinoma

por Zoon, Christine K., Wan, Wen, Graham, Laura, Bear, Harry D.
Publicado 2017

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer

por Tang, Amy H., Hoefer, Richard A., Guye, Mary L., Bear, Harry D.
Publicado 2022

Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?

por Sparkman, Brian K., Nguyen, Tuong Vi V., Smith, Steven Christopher, Bear, Harry D.
Publicado 2023

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function

por Kmieciak, Maciej, Gowda, Madhu, Graham, Laura, Godder, Kamar, Bear, Harry D, Marincola, Francesco M, Manjili, Masoud H
Publicado 2009

Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T cell subsets exposed to IL-2 versus IL-7/15

por Zoon, Christine K., Seitelman, Eric, Keller, Sara, Graham, Laura, Blevins, Tana L., Dumur, Catherine I., Bear, Harry D.
Publicado 2014

Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Wome...

por Aboalela, Noran, Lyon, Debra, Elswick, R. K., Kelly, Debra Lynch, Brumelle, Jenni, Bear, Harry D., Jackson-Cook, Colleen
Publicado 2015

Neighborhood disadvantage and biological aging biomarkers among breast cancer patients

por Shen, Jie, Fuemmeler, Bernard F., Sheppard, Vanessa B., Bear, Harry D., Song, Renduo, Chow, Wong-Ho, Zhao, Hua
Publicado 2022

Near-Infrared Imaging of Adoptive Immune Cell Therapy in Breast Cancer Model Using Cell Membrane Labeling

por Youniss, Fatma M., Sundaresan, Gobalakrishnan, Graham, Laura J., Wang, Li, Berry, Collin R., Dewkar, Gajanan K., Jose, Purnima, Bear, Harry D., Zweit, Jamal
Publicado 2014

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

por Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, Latif, Bear, Harry D, Manjili, Masoud H
Publicado 2013

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells

por Payne, Kyle K., Keim, Rebecca C., Graham, Laura, Idowu, Michael O., Wan, Wen, Wang, Xiang-Yang, Toor, Amir A., Bear, Harry D., Manjili, Masoud H.
Publicado 2016

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure

por Kmieciak, Maciej, Payne, Kyle K, Idowu, Michael O, Grimes, Margaret M, Graham, Laura, Ascierto, Maria-Libera, Wang, Ena, Wang, Xiang-Yang, Bear, Harry D, Manjili, Masoud H
Publicado 2011

Gr1(−/low)CD11b(−/low)MHCII(+) myeloid cells boost T cell anti‐tumor efficacy

por Payne, Kyle K., Aqbi, Hussein F., Butler, Savannah E., Graham, Laura, Keim, Rebecca C., Wan, Wen, Idowu, Michael O., Bear, Harry D., Wang, Xiang‐Yang, Manjili, Masoud H.
Publicado 2018

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy...

por Luker, Andrea J., Graham, Laura J., Smith, Timothy M., Camarena, Carmen, Zellner, Matt P., Gilmer, Jamie-Jean S., Damle, Sheela R., Conrad, Daniel H., Bear, Harry D., Martin, Rebecca K.
Publicado 2020

Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets

por Aqbi, Hussein F., Coleman, Cara, Zarei, Melika, Manjili, Saeed H., Graham, Laura, Koblinski, Jennifer, Guo, Chunquing, Xie, Yibin, Guruli, Georgi, Bear, Harry D., Idowu, Michael O., Habibi, Mehran, Wang, Xiang-Yang, Manjili, Masoud H.
Publicado 2020

Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity

por Yu, Xiaofei, Liu, Wenjie, Chen, Shixian, Cheng, Xueqian, Paez, Patrick A, Sun, Tuanwei, Yuan, Fang, Wei, Chunyan, Landry, Joseph W, Poklepovic, Andrew S, Bear, Harry D, Subjeck, John R, Repasky, Elizabeth, Guo, Chunqing, Wang, Xiang-Yang
Publicado 2021

Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy

por Aqbi, Hussein F., Tyutyunyk-Massey, Liliya, Keim, Rebecca C., Butler, Savannah E., Thekkudan, Theresa, Joshi, Supriya, Smith, Timothy M., Bandyopadhyay, Dipankar, Idowu, Michael O., Bear, Harry D., Payne, Kyle K., Gewirtz, David A., Manjili, Masoud H.
Publicado 2018

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

por Ascierto, Maria Libera, Idowu, Michael O, Zhao, Yingdong, Khalak, Hanif, Payne, Kyle K, Wang, Xiang-Yang, Dumur, Catherine I, Bedognetti, Davide, Tomei, Sara, Ascierto, Paolo A, Shanker, Anil, Bear, Harry D, Wang, Ena, Marincola, Francesco M, De Maria, Andrea
Publicado 2013

If we build it they will come: targeting the immune response to breast cancer

por Gatti-Mays, Margaret E., Balko, Justin M., Gameiro, Sofia R., Bear, Harry D., Prabhakaran, Sangeetha, Fukui, Jami, Disis, Mary L., Nanda, Rita, Gulley, James L., Kalinsky, Kevin, Abdul Sater, Houssein, Sparano, Joseph A., Cescon, David, Page, David B., McArthur, Heather, Adams, Sylvia, Mittendorf, Elizabeth A.
Publicado 2019